Request Deal Involvement
Abingworth, Bain Capital Life Sciences, and Venrock Healthcare led a $180m Series A round in Timberlyne Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
or
Principals
bidder
VENROCK HEALTHCARE CAPITAL PARTNERS
bidder
LILLY ASIA VENTURES
bidder
BRAIDWELL LP
bidder
ABINGWORTH MANAGEMENT
bidder
BOYU CAPITAL
target
TIMBERLYNE THERAPEUTICS
bidder
BAIN CAPITAL LIFE SCIENCES
bidder
3H HEALTH INVESTMENT
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite